doi:10.2991/jegh.k.191028.001 Petito LC, McCab M, Allen NB, OBrien MJ, Carnethon MR
found that liraglutide, an GLP-1R agonists, reduces the activated microglia load in the cortex and dentate gyrus region of hippocampus, and the activated astrocyte load in the cortex
BGM is needed before meals to give the user the chance to adjust the meal insulin dose if the pre-meal glucose is out of range at the time, while measurements over a few days will show whether the doses active before that meal require adjustment
Zepbound: Representing the next evolution in treatment, Zepbound has shown even greater promise in clinical trials, offering patients in search of Detroit weight loss a new level of efficacy
Are committed to lifestyle changes, such as healthier eating and increased physical activity
Integrating the result from the CVOTs in their meta-analysis, Sattar and colleagues found that the GLP-1 RA drug class may reduce the risk of hospital admission for HF by 11% (HR vs